Preclinical scientific studies recommend that retatrutide could influence obesity-involved most cancers progression. Inside a study led by Marathe et al., retatrutide-induced weight loss reduced tumor engraftment, delayed tumor onset, and significantly attenuated tumor advancement in pancreatic and lung cancer designs, with greater tumor suppressio